Lowinson and Ruiz's Substance Abuse: A Comprehensive Textbook

Lowinson and Ruiz's Substance Abuse, the premier text on substance abuse and addictive behaviors is now in its updated and expanded Fifth Edition. Scientific topics such as the biology of various addictions and all dimensions of clinical treatment and management are addressed by a wide range of leading contributors. Behavioral addictions are addressed also, so the text is not solely devoted to specific substances and their misuse.

Table of Contents:
Preface vii Foreword ix S E C T I O N 1 : Foundations 1 Historical Perspectives . . . . . . . . . . . . . . . . . . . . . . . . . . 1 David F. Musto and Eric D. Wish 2 Epidemiology—The United States . . . . . . . . . . . . . . . 17 Charles Winick and Jack Levinson 3 Epidemiology—A European Perspective . . . . . . . . . . 26 Icro Maremmani, Matteo Pacini, Mercedes Lovrecic, and Pier Paolo Pani S E C T I O N 2 : Determinants of Abuse and Dependence 4 Genetic Factors in the Risk for Substance Use Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36 Thomas A. Nguyen, Jaimee L. Heffner, Show W. Lin, and Robert M. Anthenelli 5 Neurobiological Factors of Drug Dependence and Addiction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55 Heath D. Schmidt, Fair M. Vassoler, and R. Christopher Pierce 6 Psychological Factors (In Determinants of Abuse and Dependence) . . . . . . . . . . . . . . . . . . . . . . . 79 Steven Shoptaw 7 Behavioral Aspects . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88 Kenneth Silverman, Anthony DeFulio, and Jeffery J. Everly 8 Sociocultural Factors and Their Implications . . . . . . 99 Nady el-Guebaly and Pedro Ruiz S E C T I O N 3 : Evaluation 9 Clinical Assessment . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107 LaVerne Hanes Stevens and Michael L. Dennis 10 Diagnosis and Classification: DSM-IV-TR and ICD-10 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117 George E. Woody and John Cacciola 11 Diagnostic Laboratory: Screening for Drug Abuse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123 Karl G. Verebey and Gerard Meenan S E C T I O N 4 : Substances of Abuse 12 Alcohol Use Disorders . . . . . . . . . . . . . . . . . . . . . . . . 138 Carlos A. Hernandez-Avila and Henry R. Kranzler 13 Opioids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161 David H. Epstein, Karran A. Phillips, and Kenzie L. Preston 14 Cocaine and Crack . . . . . . . . . . . . . . . . . . . . . . . . . . . 191 Richard P. Paczynski and Mark S. Gold 15 Cannabis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 214 Alan J. Budney, Ryan L. Vandrey, and Stephanie Fearer 16 Amphetamines and Other Stimulants . . . . . . . . . . . 238 Kevin P. Hill and Roger D. Weiss 17 Sedative–Hypnotics . . . . . . . . . . . . . . . . . . . . . . . . . . 255 Domenic A. Ciraulo and Clifford Knapp 18 Hallucinogens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 267 Robert N. Pechnick and Kathryn A. Cunningham 19 PCP/Designer Drugs/MDMA . . . . . . . . . . . . . . . . . . 277 Una D. McCann 20 Inhalants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 284 Charles W. Sharp, Matthew O. Howard, and Wynne K. Schiffer 21 Nicotine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 319 Joy M. Schmitz and Angela L. Stotts 22 Caffeine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 335 Laura M. Juliano, Britta L. Anderson, and Roland R. Griffiths 23 Anabolic–Androgenic Steroids . . . . . . . . . . . . . . . . . 354 Laurence M. Westreich S E C T I O N 5 : Compulsive and Addictive Behaviors 24 Eating Disorders and Substance Use Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 373 Harry A. Brandt, Steven F. Crawford, and Katherine A. Halmi 25 Pathologic Gambling . . . . . . . . . . . . . . . . . . . . . . . . . 384 Elise E. DeVito and Marc Potenza 26 Sexual Addiction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 393 Virginia A. Sadock 27 Internet Addiction . . . . . . . . . . . . . . . . . . . . . . . . . . . 284 Philippe Weintraub, Thomas M. Dunn, Joel Yager, and Zebulon Taintor S E C T I O N 6 : Treatment Approaches" Part 1: Neurobiologic Treatments 28 Methadone Maintenance . . . . . . . . . . . . . . . . . . . . . . 419 Andrew J. Saxon and Karen Miotto 29 Buprenorphine in the Treatment of Opioid Dependence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 437 D. Andrew Tompkins and Eric C. Strain 30 Naltrexone Pharmacotherapy . . . . . . . . . . . . . . . . . . 447 Emily Harrison and Ismene Petrakis 31 Vaccines for Substance Abuse . . . . . . . . . . . . . . . . . . 457 Frank M. Orson, Mark J. Biscone, Berma M. Kinsey, and Thomas R. Kosten 32 Acupuncture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 466 Ji-Sheng Han and Cai-Lian Cui 33 Alcohol Abstinence Management . . . . . . . . . . . . . . . 477 Richard N. Rosenthal 34 Alternative Pharmacotherapies for Opioid Addiction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 494 Paul J. Fudala and Rolley E. Johnson 35 Sedative-Hypnotics Abstinence . . . . . . . . . . . . . . . . . 501 R.C. Oude Voshaar 36 Nicotine Dependence Management . . . . . . . . . . . . . 510 Douglas Ziedonis, David Kalman, Chris W. Johnson, and Lisa A. Mistler Part 2: Psychosocial and Other Treatments 37 Self-Help Programs Focused on Substance Use: Active Ingredients and Outcomes . . . . . . . . . . . . . . . 523 Rudolf H. Moos and Christine Timko 38 Alternative Support Groups . . . . . . . . . . . . . . . . . . . . 533 Arthur T. Horvath 39 The Therapeutic Community . . . . . . . . . . . . . . . . . . 543 William B. O’Brien, J. Gabriel Piedrahita, and Francisco (Sebastian) P. Bacatan, Jr. 40 Network Therapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . 551 Marc Galanter and Helen Dermatis 41 Individual Psychotherapy . . . . . . . . . . . . . . . . . . . . . 562 Joan E. Zweben 42 Group Therapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 575 Arnold M. Washton 43 Family/Couples Approaches to Treatment Engagement and Therapy . . . . . . . . . . . . . . . . . . . . . 584 William Fals-Stewart and Wendy K. K. Lam 44 Cognitive Behavioral Therapy . . . . . . . . . . . . . . . . . . 593 Kathleen M. Carroll 45 Contingency Management in the Treatment of Substance Use Disorders: Trends in the Literature . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 603 Stephen T. Higgins, Stacey C. Sigmon, and Sarah H. Heil 46 Motivational Interviewing and Enhancement . . . . . 622 Carlo C. DiClemente, Onna R. Van Orden, and Katherine S. Wright 47 Relapse Prevention . . . . . . . . . . . . . . . . . . . . . . . . . . . 633 Dennis C. Daley, G. Alan Marlatt, and Antoine Douaihy S E C T I O N 7 : Management of Associated Medical Conditions 48 Maternal and Neonatal Complications of Alcohol and Other Drugs . . . . . . . . . . . . . . . . . . . . . . 648 Karol Kaltenbach and Hendrée Jones 49 Medical Complications of Drug Use/Dependence . . 663 Joshua D. Lee, Jennifer McNeely, and Marc N. Gourevitch 50 Psychiatric Complications of HIV-1 Infection and Drug Abuse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 682 Harold W. Goforth, L. Brett Caram, Jorge Maldonado, Pedro Ruiz, and Francisco Fernandez 51 Acute and Chronic Pain . . . . . . . . . . . . . . . . . . . . . . . 695 Russell K. Portenoy 52 Substance Use Disorders in Individuals with Co-occurring Psychiatric Disorders . . . . . . . . . . . . . 721 Sylvia J. Dennison 53 Medication Interactions . . . . . . . . . . . . . . . . . . . . . . . 730 Carolina L. Haass-Koffler and Elinore F. McCance-Katz S E C T I O N 8 : Models of Prevention 54 School-Based Programs . . . . . . . . . . . . . . . . . . . . . . . 742 Gilbert J. Botvin and Kenneth W. Griffin 55 Harm Reduction: New Drug Policies and Practices . . 754 Ernest Drucker, Robert G. Newman, Ethan Nadelmann, Alex Wodak, Daniel Wolfe, David Marsh, Eugene Oscapella, Jennifer Mcneely, Yujiang Jia, and Kasia Malinowska-Semprucht 56 Work Setting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 777 Paul F. Engelhart and Cindy Taormina S E C T I O N 9 : Life Cycle 57 Adolescent Substance Abuse . . . . . . . . . . . . . . . . . . . 786 Robert Milin and Selena Walker 58 The Older Drug Abuser . . . . . . . . . . . . . . . . . . . . . . . 802 Bennett W. Fletcher and Wilson M. Compton S E C T I O N 1 0 : Special Populations 59 African Americans: Alcohol and Substance Abuse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 813 William B. Lawson, Jessica Herrera, and Robert G. Lawson 60 Hispanic Americans . . . . . . . . . . . . . . . . . . . . . . . . . . 819 Pedro Ruiz 61 Asian Americans and Pacific Islanders . . . . . . . . . . . 829 John W. Tsuang and Edmond H. Pi 62 American Indians and Alaska Natives . . . . . . . . . . . 837 Daniel Dickerson 63 Women and Addiction . . . . . . . . . . . . . . . . . . . . . . . . 847 Shelly F. Greenfield, Sudie E. Back, Katie Lawson, and Kathleen T. Brady 64 Gays, Lesbians, and Bisexuals . . . . . . . . . . . . . . . . . . 871 Robert Paul Cabaj 65 Incarcerated Populations . . . . . . . . . . . . . . . . . . . . . . 881 Timothy W. Kinlock, Michael S. Gordon, and Robert P. Schwartz 66 Substance Use Disorders among Health Care Professionals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 892 J. Wesley Boyd and John R. Knight 67 The Homeless . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 901 Jacqueline Maus Feldman 68 Disability, Impairment, and Addiction . . . . . . . . . . . 908 Stuart Gitlow 69 New Immigrants and Refugees . . . . . . . . . . . . . . . . . 918 Joseph Westermeyer 70 Substance Use in the Armed Forces . . . . . . . . . . . . . 926 Robert M. Bray and Michael R. Pemberton S E C T I O N 1 1 : Training and Education 71 Medical Education on Addiction . . . . . . . . . . . . . . . 937 Karen Drexler 72 Psychologists: Training and Education . . . . . . . . . . . 949 D. Baron, C.J. Combs, and A.P. Wells 73 Nursing Education in Addictions and Substance Abuse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 957 Betty D. Morgan and Donna M. White, and Colleen T. LaBelle 74 Social Worker Education and Training in the Care of Persons with Substance Use Disorders . . . . . . . . . . . 965 Michelle Tuten 75 Counselor Training and Education . . . . . . . . . . . . . . 971 Gregory S. Brigham, Natasha Slesnick, and Grant Schroeder 76 Other Mental Health Professionals . . . . . . . . . . . . . . 979 E. Akerele, N. Nahar, and J. Cerimele S E C T I O N 1 2 : Policy Issues 77 Drug Policy: A Biological Science Perspective . . . . . 988 Robert L. DuPont, Bertha K. Madras, and Per Johansson 78 Substance Abuse Policy and Payment . . . . . . . . . . . 1011 Anita Everett 79 Forensics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1019 Ihsan M. Salloum 80 Clinical and Societal Implications of Drug Legalization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1034 Benjamin R. Nordstrom and Herbert D. Kleber 81 Future Directions . . . . . . . . . . . . . . . . . . . . . . . . . . . 1046 Pedro Ruiz and Eric C. Strain